Follow
Erika Rosivatz
Erika Rosivatz
Unknown affiliation
Verified email at imperial.ac.uk
Title
Cited by
Cited by
Year
Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer
E Rosivatz, I Becker, K Specht, E Fricke, B Luber, R Busch, H Höfler, ...
The American journal of pathology 161 (5), 1881-1891, 2002
7952002
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
A Alimonti, C Nardella, Z Chen, JG Clohessy, A Carracedo, LC Trotman, ...
The Journal of clinical investigation 120 (3), 681-693, 2010
4132010
Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down‐regulation of E‐cadherin
CC Alves, E Rosivatz, C Schott, R Hollweck, I Becker, M Sarbia, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007
2342007
Widely Used Pesticides with Previously Unknown Endocrine Activity Revealed as in Vitro Antiandrogens
F Orton, E Rosivatz, M Scholze, A Kortenkamp
Environmental health perspectives 119 (6), 794-800, 2011
2122011
Analysis of the E-cadherin repressor Snail in primary human cancers
KF Becker, E Rosivatz, K Blechschmidt, E Kremmer, M Sarbia, H Höfler
Cells Tissues Organs 185 (1-3), 204-212, 2007
1872007
Response to a critique of the European Commission Document,“State of the Art Assessment of Endocrine Disrupters” by Rhomberg and colleagues–letter to the editor
A Kortenkamp, O Martin, R Evans, F Orton, R McKinlay, E Rosivatz, ...
Critical reviews in toxicology 42 (9), 787-789, 2012
1702012
A small-molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)
E Rosivatz, JG Matthews, NQ McDonald, X Mulet, KK Ho, N Lossi, ...
ACS chemical biology 1 (12), 780-790, 2006
1592006
Mixture effects at very low doses with combinations of anti-androgenic pesticides, antioxidants, industrial pollutant and chemicals used in personal care products
F Orton, S Ermler, S Kugathas, E Rosivatz, M Scholze, A Kortenkamp
Toxicology and applied pharmacology 278 (3), 201-208, 2014
1262014
Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract
E Rosivatz, KF Becker, E Kremmer, C Schott, K Blechschmidt, H Höfler, ...
Virchows Archiv 448, 277-287, 2006
1072006
Neoexpression of N‐cadherin in E‐cadherin positive colon cancers
E Rosivatz, I Becker, M Bamba, C Schott, J Diebold, D Mayr, H Höfler, ...
International journal of cancer 111 (5), 711-719, 2004
1032004
State of the art assessment of endocrine disrupters. Final report
A Kortenkamp, O Martin, M Faust, R Evans, R McKinlay, F Orton, ...
Brussels: European Commission 442, 2011
832011
Relationship between E‐cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl‐2 expression and Ki‐67 staining in diffuse‐type gastric carcinoma
E Fricke, G Keller, I Becker, E Rosivatz, C Schott, S Plaschke, M Rudelius, ...
International journal of cancer 104 (1), 60-65, 2003
622003
Removal or masking of phosphatidylinositol (4, 5) bisphosphate from the outer mitochondrial membrane causes mitochondrial fragmentation
E Rosivatz, R Woscholski
Cellular signalling 23 (2), 478-486, 2011
492011
Competitive androgen receptor antagonism as a factor determining the predictability of cumulative antiandrogenic effects of widely used pesticides
F Orton, E Rosivatz, M Scholze, A Kortenkamp
Environmental health perspectives 120 (11), 1578-1584, 2012
462012
Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis
M Kremer, L Quintanilla-Martinez, M Fuchs, A Gamboa-Dominguez, ...
Carcinogenesis 24 (12), 1879-1886, 2003
422003
Effects of common pesticides on prostaglandin D2 (PGD2) inhibition in SC5 mouse Sertoli cells, evidence of binding at the COX-2 active site, and implications for endocrine …
S Kugathas, K Audouze, S Ermler, F Orton, E Rosivatz, M Scholze, ...
Environmental Health Perspectives 124 (4), 452-459, 2016
392016
Inhibiting PTEN
E Rosivatz
Biochemical Society Transactions 35 (2), 257-259, 2007
372007
Signal transduction of constitutively active protein kinase C epsilon
D Garczarczyk, E Toton, V Biedermann, E Rosivatz, F Rechfeld, ...
Cellular signalling 21 (5), 745-752, 2009
322009
Specific N-terminal protein labelling: use of FMDV 3C pro protease and native chemical ligation
GK Busch, EW Tate, PRJ Gaffney, E Rosivatz, R Woscholski, ...
Chemical communications, 3369-3371, 2008
282008
Effect of tumor‐associated mutant E‐cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3
M Fuchs, C Hermannstädter, K Specht, P Knyazev, A Ullrich, E Rosivatz, ...
Journal of cellular physiology 202 (3), 805-813, 2005
282005
The system can't perform the operation now. Try again later.
Articles 1–20